GGrantIndex
← Leaderboards

Jefferson Kinney

University Of Nevada Reno

$4,056,211
Attributed
$5,077,349
Total exposure
9
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.4M · FY201125
$5M$3.8M$2.5M$1.3M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$15,152,333 · 10

By mechanism

P20$13,289,384 · 8
R01$1,261,373 · 1
R56$601,576 · 1

Top collaborators

Most similar at University Of Nevada Reno

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos

Research focus

Alzheimer&AposNerve DegenerationNeurodegenerative DisordersCenters Of Research ExcellenceBrainInvestigationAffectAmyloid Beta-ProteinNeuronsNeurotransmittersBehavioralS DiseaseInflammatoryEvaluationExhibitsGrantAnimal ModelFundingSignal TransductionDisease ProgressionInsightInflammatory ResponseLiteratureImmune Function

Grant awards (21)

Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) CNTN - Resubmission$1,001,755
P20 · FY2025 · GM
Brain Structure-Function Associations in Predicting Cognitive Resilience$61,504
P20 · FY2025 · GM
Core E - Translational Biomarker Core$56,713
P20 · FY2025 · GM · contact PI
Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) CNTN - Resubmission$2,264,085
P20 · FY2024 · GM
Core E - Translational Biomarker Core$137,254
P20 · FY2024 · GM · contact PI
Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) CNTN - Resubmission$2,232,255
P20 · FY2023 · GM
Core E - Translational Biomarker Core$149,194
P20 · FY2023 · GM · contact PI
Beyond Reserve: Dynamic Neurocognitive Adaptation$117,824
P20 · FY2023 · GM
Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) CNTN - Resubmission$2,252,411
P20 · FY2022 · GM
Core E - Translational Biomarker Core$145,969
P20 · FY2022 · GM · contact PI
Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) CNTN - Resubmission$2,324,478
P20 · FY2021 · GM · contact PI
Aging and hyperglycemia alter molecular mechanisms and hippocampal oscillations consistent with Alzheimer's disease$657,585
R01 · FY2021 · AG · contact PI
CORE A: Administrative Core$461,401
P20 · FY2021 · GM · contact PI
Aging and hyperglycemia alter molecular mechanisms and hippocampal oscillations consistent with Alzheimer's disease$603,788
R01 · FY2020 · AG · contact PI
Aging and hyperglycemia alter molecular mechanisms and hippocampal oscillations consistent with Alzheimer's disease$601,576
R56 · FY2019 · AG · contact PI
Project 3: Immune Markers Linking Pathogenesis in Animal Models and Human Neurodegenerative Disease$332,359
P20 · FY2019 · GM · contact PI
Project 3: Immune Markers Linking Pathogenesis in Animal Models and Human Neurodegenerative Disease$308,497
P20 · FY2018 · GM · contact PI
Project 3: Immune Markers Linking Pathogenesis in Animal Models and Human Neurodegenerative Disease$384,505
P20 · FY2017 · GM · contact PI
Project 3: Immune Markers Linking Pathogenesis in Animal Models and Human Neurodegenerative Disease$521,987
P20 · FY2016 · GM · contact PI
Project 3: Immune Markers Linking Pathogenesis in Animal Models and Human Neurodegenerative Disease$445,204
P20 · FY2015 · GM · contact PI
AN INVESTIGATION OF INHIBITORY SIGNALING IN ANIMAL MODELS OF PSYCHIATRIC DISORDE$91,989
P20 · FY2011 · RR · contact PI